A-3.001, r. 1 - Regulation respecting medical aid

Full text
28. The Commission shall assume the cost of leasing a transcutaneous nerve stimulator only for the first 3 months of its use.
At the end of that period, the Commission shall assume the cost of purchasing such device, less the initial leasing cost where the medical prescription for the use of the device is renewed.
The cost of leasing, purchasing or renewing a transcutaneous nerve stimulator includes the accessories required for its use.
The accessories are wires, batteries, battery charger and either electrodes, gel and hypoallergenic adhesive tape, or self-adhesive rigid or flexible electrodes, where the health professional in charge of the worker prescribes the use for such electrodes.
The cost of purchasing and renewing a transcutaneous nerve stimulator may not exceed $590 plus, where applicable, the cost of self-adhesive rigid or flexible electrodes, up to $400 for the first year.
O.C. 288-93, s. 28; 506-2019O.C. 506-2019, s. 3.
28. The Commission shall assume the cost of leasing a transcutaneous nerve stimulator only for the first 3 months of its use.
At the end of that period, the Commission shall assume the cost of purchasing such device, less the initial leasing cost where the medical prescription for the use of the device is renewed.
The cost of leasing, purchasing or renewing a transcutaneous nerve stimulator includes the accessories required for its use.
The accessories are wires, batteries, battery charger and either electrodes, gel and hypoallergenic adhesive tape, or self-adhesive rigid or flexible electrodes, where the physician in charge of the worker prescribes the use for such electrodes.
The cost of purchasing and renewing a transcutaneous nerve stimulator may not exceed $590 plus, where applicable, the cost of self-adhesive rigid or flexible electrodes, up to $400 for the first year.
O.C. 288-93, s. 28; 506-2019O.C. 506-2019, s. 3.
28. The Commission shall assume the cost of leasing a transcutaneous nerve stimulator only for the first 3 months of its use.
At the end of that period, the Commission shall assume the cost of purchasing such device, less the initial leasing cost where the medical prescription for the use of the device is renewed.
The cost of purchasing and renewing a transcutaneous nerve stimulator may not exceed $590.
O.C. 288-93, s. 28.